cetrorelix and Hematologic-Neoplasms

cetrorelix has been researched along with Hematologic-Neoplasms* in 1 studies

Trials

1 trial(s) available for cetrorelix and Hematologic-Neoplasms

Article	Year
Effect of the gonadotropin-releasing hormone antagonist cetrorelix on the prevention of chemotherapy-induced ovarian damage in women with hematological malignancy. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2012, Volume: 118, Issue:1 Topics: Adolescent; Adult; Antineoplastic Agents; Female; Gonadotropin-Releasing Hormone; Hematologic Neoplasms; Hormone Antagonists; Humans; Ovarian Diseases; Retrospective Studies; Treatment Outcome; Young Adult	2012

Article

Year

Effect of the gonadotropin-releasing hormone antagonist cetrorelix on the prevention of chemotherapy-induced ovarian damage in women with hematological malignancy.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2012, Volume: 118, Issue:1

Topics: Adolescent; Adult; Antineoplastic Agents; Female; Gonadotropin-Releasing Hormone; Hematologic Neoplasms; Hormone Antagonists; Humans; Ovarian Diseases; Retrospective Studies; Treatment Outcome; Young Adult

2012